| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/06/2005 | US6939958 can be used to express heterologous genes of interest within aleurone cells of a plant; cultures and transgenic plants; hybridizing nucleotide sequence |
| 09/06/2005 | US6939956 Variable region of the monoclonal antibody against HBV S-surface antigen and a gene encoding the same |
| 09/06/2005 | US6939953 Polypeptide for use in the treatment of infections, asthma, inflammation, allergies, diabebtes, nervous system, glomerulonephritis, arthritis, bowel defects, psoriasis, diabetes, obesity, atherosclerosis |
| 09/06/2005 | US6939949 Protein for use in diagnosis and treatment of cancer |
| 09/06/2005 | US6939851 Serine proteinase inhibitors |
| 09/06/2005 | US6939849 Recombinant PDGF A-chain homodimers and methods of use |
| 09/06/2005 | US6939712 for expression inhibition/knockout of collagen, tumor necrosis factor, tat genes/proteins, and immunoglobulins |
| 09/06/2005 | US6939711 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 09/06/2005 | US6939710 Genes encoding sulfate assimilation proteins |
| 09/06/2005 | US6939705 treating lactobacillus (L. johnsonii La1) with sodium chloride and heating; comprises Bifidobacterium |
| 09/06/2005 | US6939704 Enhanced expression of proteins in genetically modified fungi |
| 09/06/2005 | US6939703 Amylolytic enzymes derived from the B.licheniformis α-amylase, having improved characteristics |
| 09/06/2005 | US6939701 Polypeptides having oxaloacetate hydrolase activity and nucleic acids encoding same |
| 09/06/2005 | US6939700 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 09/06/2005 | US6939699 A heat-stable enzyme having a DNA helicase activity, and a structure-specific endonuclease activity; obtained by cloning a gene encoding the enzyme from chromosomal DNA of a a sulfur-metabolizing thermophilic archaebacteria |
| 09/06/2005 | US6939695 Nucleotide sequences coding polypeptide for generating amino acids for use in animal and human foods, medicines and nutrients |
| 09/06/2005 | US6939694 Nucleotide sequences which code for the citB gene |
| 09/06/2005 | US6939691 malonyl CoA synthetase (MatB)/malonate transporter (MatC); proprionyl CoA carboxylase (pcc); |
| 09/06/2005 | US6939689 site-directed mutagenesis; annealing |
| 09/06/2005 | US6939680 Nucleotide sequences coding protein for use in the treatment and prevention of nervous system, dyskinesia, kidney, vascular, circadian rhythms and vision defects |
| 09/06/2005 | US6939679 NADE binding proteins |
| 09/06/2005 | US6939676 Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics |
| 09/06/2005 | US6939674 Medicine response assay in respiratory disease |
| 09/06/2005 | US6939672 Nucleotide squences extraction solution; for use recovering preferential nucleic acids |
| 09/06/2005 | US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/06/2005 | US6939541 Polypeptide for use in the treatment of viral diseases and cancer |
| 09/06/2005 | CA2296064C Infectious vectors and clones of plants derived from the turnip mosaic virus (tumv) |
| 09/06/2005 | CA2294470C Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| 09/06/2005 | CA2261041C Bacillus thuringiensis strains showing improved production of certain lepidopteran-toxic crystal proteins |
| 09/06/2005 | CA2258239C Detection of ligand interaction with polymeric material |
| 09/06/2005 | CA2250693C Compositions and methods for taxol biosynthesis |
| 09/06/2005 | CA2160034C Gibbon ape leukemia virus-based retroviral vectors |
| 09/06/2005 | CA2139928C High alkaline serine proteases |
| 09/03/2005 | CA2499190A1 New fluorescent genetic fragments and fish |
| 09/03/2005 | CA2457303A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/02/2005 | WO2004073646A2 Treatment of pain through expression of opioid receptors |
| 09/02/2005 | CA2555996A1 Treatment of pain through expression of opioid receptors |
| 09/02/2005 | CA2499160A1 Releasable polymer arrays |
| 09/01/2005 | WO2005080981A1 Method of judging the extent of vasculopathy |
| 09/01/2005 | WO2005080597A1 Method for diagnosing colorectal cancers |
| 09/01/2005 | WO2005080592A1 Method of immobilizing nucleic acid aptamers |
| 09/01/2005 | WO2005080584A1 PROCESS FOR, WITH USE OF α-AMINO- ϵ -CAPROLACTAM RACEMASE, PRODUCING MIXTURE OF D- AND L-AMINO ACID AMIDE, PRODUCING D- OR L-AMINO ACID, AND PRODUCING D- OR L-AMINO ACID AMIDE |
| 09/01/2005 | WO2005080582A1 Cytoplasmic localization dna and rna |
| 09/01/2005 | WO2005080581A2 Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| 09/01/2005 | WO2005080580A2 Use of the myb4 transcriptional factor from rice to increase the production of secondary metabolites by transformed plants |
| 09/01/2005 | WO2005080579A2 Taxadiene biosynthesis |
| 09/01/2005 | WO2005080578A2 Desaturase enzymes |
| 09/01/2005 | WO2005080577A2 Method for modulating gibberellic acid-dependent processes in plants |
| 09/01/2005 | WO2005080576A1 A method for regulating plant growth |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080574A1 Transgenic mouse model and method for evaluating glucocerebrosidase deficiencies |
| 09/01/2005 | WO2005080573A1 Recombinant viral vectors to promote neuronal cell survival and uses thereof |
| 09/01/2005 | WO2005080572A1 Triterpene hydroxylase |
| 09/01/2005 | WO2005080571A1 The usage of mad-box genes in fruit & seed development by regulating active gibberellin synthesis |
| 09/01/2005 | WO2005080568A1 Methods and compositions for treatment or prevention of secondary ischemic injury |
| 09/01/2005 | WO2005080567A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals |
| 09/01/2005 | WO2005080566A1 Isolating, positioning, and sequencing single molecules |
| 09/01/2005 | WO2005080565A1 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 09/01/2005 | WO2005080557A1 Multiple stress-inducible peroxidase promoter derived from ipomoea batatas |
| 09/01/2005 | WO2005080552A1 Methods for genetic diversification in gene conversion active cells |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080432A2 Cdr-repaired antibodies |
| 09/01/2005 | WO2005080431A2 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 09/01/2005 | WO2005080423A1 Antifungal peptides |
| 09/01/2005 | WO2005080421A1 Novel polygalacturonase inhibitor protein and its use |
| 09/01/2005 | WO2005080420A2 Hyphal growth in fungi |
| 09/01/2005 | WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof |
| 09/01/2005 | WO2005080418A2 Multimerised hiv fusion inhibitors |
| 09/01/2005 | WO2005080417A2 Recombinant viruses with heterologous envelope proteins |
| 09/01/2005 | WO2005080414A1 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 09/01/2005 | WO2005080411A1 3’-terminal nucleoside unit containing phosphoramidite |
| 09/01/2005 | WO2005080410A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | WO2005080409A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/01/2005 | WO2005080404A1 Silyl linker for solid-phase synthesis of nucleic acid |
| 09/01/2005 | WO2005079862A1 USE OF RESISTIN ANTISENSE OLIGONUCLEOTIDES AND/OR siRNA MOLECULES IN THE TREATMENT OF RHEUMATOID ARTHRITIS |
| 09/01/2005 | WO2005079859A1 Target directional carrier |
| 09/01/2005 | WO2005079815A2 Methods and reagents for treating autosomal dominant diseases of the eye |
| 09/01/2005 | WO2005079533A2 Methods and compositions for mediating gene silencing |
| 09/01/2005 | WO2005079532A2 Methods and compositions for enhancing risc activity in vitro and in vivo |
| 09/01/2005 | WO2005079453A2 Low maintenance turfgrass |
| 09/01/2005 | WO2005079389A2 In vivo assembly of transcription units |
| 09/01/2005 | WO2005079363A2 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 09/01/2005 | WO2005079342A2 Methods for coupling resistance alleles in tomato |
| 09/01/2005 | WO2005079271A2 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 09/01/2005 | WO2005079267A2 Methods for protein production |
| 09/01/2005 | WO2005079236A2 Rna-mediated interference to control disease in terrestrial and aquaculture animals |
| 09/01/2005 | WO2005079232A2 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 09/01/2005 | WO2005079183A2 Method for production of c30-aldehyde carotenoids |
| 09/01/2005 | WO2005079170A2 Polypeptide participating in pyridoxine biosynthesis, a polynucleotide coding the polypeptide and those uses |
| 09/01/2005 | WO2005079168A2 A novel stay-green gene and method for preparing stay-green transgenic plants |
| 09/01/2005 | WO2005079162A2 Engrafted plants resistant to viral diseases and methods of producing same |
| 09/01/2005 | WO2005065711A3 Mammalian receptor proteins; related reagents and methods |
| 09/01/2005 | WO2005058953A3 Ogh fusion polypeptides and therapeutic uses thereof |
| 09/01/2005 | WO2005056786A3 Sugar kinases with expanded substrate specificity and their use |
| 09/01/2005 | WO2005054283A3 Clp-protease as target for herbicides |
| 09/01/2005 | WO2005052191A8 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2005 | WO2005049842A3 Improved targeted dna insertion in plants |
| 09/01/2005 | WO2005043992A9 Attention-deficient hyperactivity disorder (adhd) model mouse |
| 09/01/2005 | WO2005040388A3 Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
| 09/01/2005 | WO2005040187A3 The use of sirna silencing in the prevention of metastasis |